1) Strong Financial Performance
- CME Group reported record third-quarter revenue of $1.7 billion, a 13% increase YoY.
- Average daily volume reached 29.4 million contracts, up 16% YoY, marking the highest third-quarter volume in the company's history.
- Adjusted net income was $1.1 billion, resulting in adjusted diluted EPS of $3.02, up 13% from Q3 2025.
- The company returned nearly $1 billion to shareholders, with $465 million in dividends and $524 million in share repurchases.

2) Volume and Open Interest Growth
- Open interest at quarter-end was 128 million contracts, increasing to over 133 million by early October, indicating strong market engagement.
- International business saw record average daily volume of 9 million contracts, up 22% YoY, driven by significant growth in energy (up 40%), agricultural (up 28%), and equity index products (up 24%).
- The company emphasized the importance of capital efficiency, saving customers over $100 billion daily in margin savings.

3) Product Innovation and Strategy
- CME launched several new products, including Single Stock futures and expanded 24/7 trading for Gold and Silver contracts.
- The company is on track for the launch of CME Securities Clearing on December 7, 2026, ahead of the SEC's Treasury clearing mandate.
- Continued focus on technology innovation, including cloud migration with Google Cloud, is expected to enhance operational efficiency and client service.

4) Challenges and Regulatory Considerations
- The CFTC's extended comment period for Compute Futures remains a hurdle, with no clear timeline for approval.
- Concerns from commercial participants regarding the 24/7 trading of certain products have led to a cautious approach in launching new contracts.
- The ongoing lawsuit regarding perpetual contracts raises questions about future product offerings and market dynamics, but CME remains confident in its legal position.

5) Outlook and Guidance
- CME is tracking 12% ahead of last year's record volume year-to-date and expects to deliver another record year.
- The company aims to maintain strong earnings and capital efficiencies while continuing to innovate and expand its product offerings.
- Future growth will depend on regulatory developments and the successful launch of new products, particularly in the context of evolving market demands.

Bottom line: CME Group's strong Q3 performance, characterized by record revenues and volume growth, positions it well for continued success. The focus on innovation and capital efficiency, alongside strategic product launches, supports a positive outlook for shareholders, despite regulatory challenges and market uncertainties.